Q4 2023 · 13F-HR
Parkman Healthcare Partners LLCholdings as filed
Filed 2024-02-14 · accession 0001420506-24-000380
$709.9M
Reported value
89
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $37.7M | 5.32% | 652,803 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $35.5M | 5.00% | 161,539 | Common | SOLE |
| 216648402 | — | COOPER COS INC | $28.5M | 4.01% | 75,183 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $28.0M | 3.94% | 225,615 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $27.0M | 3.80% | 356,806 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $21.1M | 2.98% | 102,891 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $21.1M | 2.97% | 103,746 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $20.7M | 2.91% | 513,032 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $19.2M | 2.71% | 88,675 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $18.5M | 2.60% | 140,116 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $17.7M | 2.50% | 61,524 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $17.3M | 2.43% | 156,727 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $16.8M | 2.37% | 267,594 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $16.4M | 2.32% | 67,458 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $16.0M | 2.25% | 738,589 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $14.5M | 2.04% | 405,232 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $14.3M | 2.02% | 360,467 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $13.6M | 1.91% | 294,788 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $13.3M | 1.88% | 186,272 | Common | SOLE |
| N72482123 | — | QIAGEN NV | $10.9M | 1.53% | 250,000 | Common | SOLE |
| G5269C101 | — | KINIKSA PHARMACEUTICALS LTD | $10.8M | 1.52% | 615,693 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $10.7M | 1.51% | 211,400 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $10.0M | 1.41% | 504,742 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $9.3M | 1.32% | 168,262 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $9.2M | 1.29% | 1,018,812 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $9.1M | 1.29% | 625,749 | Common | SOLE |
| 592688105 | MTD | METTLER TOLEDO INTERNATIONAL | $9.1M | 1.28% | 7,500 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $9.1M | 1.28% | 2,498,624 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $9.0M | 1.27% | 561,025 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $8.3M | 1.17% | 18,081 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $7.7M | 1.09% | 357,156 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $7.5M | 1.06% | 240,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $7.1M | 1.00% | 651,625 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $6.9M | 0.97% | 167,001 | Common | SOLE |
| 82710M100 | SILKUSD | SILK RD MED INC | $6.7M | 0.94% | 545,235 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $6.5M | 0.92% | 237,316 | Common | SOLE |
| 405024100 | HAE | HAEMONETICS CORP MASS | $6.0M | 0.84% | 69,940 | Common | SOLE |
| 05105P107 | AUGX | AUGMEDIX INC | $5.9M | 0.84% | 1,015,814 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $5.7M | 0.80% | 312,889 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $5.4M | 0.76% | 529,877 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $5.4M | 0.76% | 92,871 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $5.3M | 0.75% | 10,000 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $5.2M | 0.73% | 1,202,431 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $5.1M | 0.72% | 100,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $5.0M | 0.70% | 80,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $5.0M | 0.70% | 82,009 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT FINL CORP | $4.9M | 0.70% | 1,580,865 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $4.7M | 0.67% | 247,664 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $4.7M | 0.66% | 150,816 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $4.6M | 0.65% | 130,265 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $4.4M | 0.62% | 59,867 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $4.3M | 0.61% | 157,817 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $4.3M | 0.60% | 120,652 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $4.3M | 0.60% | 1,425,204 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $4.1M | 0.57% | 100,734 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $4.0M | 0.57% | 232,942 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $4.0M | 0.56% | 146,366 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $4.0M | 0.56% | 754,885 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $3.8M | 0.54% | 237,762 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $3.6M | 0.50% | 253,947 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.5M | 0.49% | 205,317 | Common | SOLE |
| 868459108 | SUPN | SUPERNUS PHARMACEUTICALS INC | $3.5M | 0.49% | 119,417 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $3.4M | 0.48% | 1,019,156 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $3.4M | 0.47% | 300,750 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $3.3M | 0.46% | 674,787 | Common | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $3.1M | 0.44% | 50,000 | PUT | SOLE |
| 825704109 | SIBN | SI-BONE INC | $3.1M | 0.43% | 145,575 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $2.6M | 0.37% | 175,500 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $2.6M | 0.37% | 429,892 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $2.5M | 0.35% | 219,448 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $2.3M | 0.33% | 603,497 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $2.3M | 0.32% | 890,099 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $1.6M | 0.23% | 696,470 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.6M | 0.22% | 38,678 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $1.4M | 0.19% | 120,652 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $1.3M | 0.19% | 603,620 | Common | SOLE |
| 641871108 | — | AMBRX BIOPHARMA INC | $1.2M | 0.18% | 87,678 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $1.2M | 0.17% | 101,767 | Common | SOLE |
| 02080L102 | TKNO | ALPHA TEKNOVA INC | $1.1M | 0.15% | 282,236 | Common | SOLE |
| H82027105 | SOPH | SOPHIA GENETICS SA | $941,986 | 0.13% | 199,997 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $904,960 | 0.13% | 212,432 | Common | SOLE |
| 29772L108 | ETON | ETON PHARMACEUTICALS INC | $872,356 | 0.12% | 199,168 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $712,945 | 0.10% | 253,717 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $684,343 | 0.10% | 103,375 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $650,222 | 0.09% | 65,679 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $643,408 | 0.09% | 767,332 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $569,402 | 0.08% | 96,837 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $153,384 | 0.02% | 102,256 | Common | SOLE |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $57,775 | 0.01% | 110,658 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.